Human Vaccines & Immunotherapeutics

Papers
(The median citation count of Human Vaccines & Immunotherapeutics is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Characterizing adolescent vaccination in publicly funded national immunization programs in Latin America and the Caribbean: A review of the literature339
Factors influencing COVID-19 vaccination intention among overseas and domestic Chinese university students: a cross-sectional survey286
Coadministration of seasonal influenza and COVID-19 vaccines: A systematic review of clinical studies171
Immunogenicity and safety of human diploid cell vaccine (HDCV) vs. purified Vero cell vaccine (PVRV) vs. purified chick embryo cell vaccine (PCECV) used in post-exposure prophylaxis: a systematic revi149
Associations between vaccination clinic factors and DTaP dropout in China: A cross-sectional study103
Geographical and time trends of measles incidence and measles vaccination coverage and their correlation in Nigeria85
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine administered in a prime-boost regimen among Chinese infants: a randomized, double blind phase III clinical trial77
Community based participatory research as a promising practice for addressing vaccine hesitancy, rebuilding trust and addressing health disparities among racial and ethnic minority communities76
Modeled impact of the COVID-19 pandemic and associated reduction in adult vaccinations on herpes zoster in the United States76
Review of the epidemiology, diagnosis and management of invasive meningococcal disease in Vietnam68
Correction65
Booster vaccines dose reduced mortality in hospitalized COVID-19 patients requiring oxygen supplementation: Evidence from the Beijing Omicron outbreak63
Estimation of single-dose varicella vaccine effectiveness in South Korea using mathematical modeling62
Factors influencing COVID-19 vaccine acceptance and hesitancy: Correspondence60
Plasma therapy: a passive resistance against the deadliest58
Human vaccines & immunotherapeutics news: July 202058
Human vaccines & immunotherapeutics: News October 202257
The public health impact of recombinant herpes zoster vaccination in adults over 50 years in Spain57
Willingness of college students to receive COVID-19 heterologous vaccination in Taizhou, China57
Systematic literature review and meta-analysis on the prevalence of rotavirus genotypes in Asia from 2015 to 202157
Assessment of COVID-19 vaccine take-up and its predictors among healthcare professionals in public hospitals, Addis Ababa, Ethiopia: Facility-based cross-sectional study56
Impact of propensity to COVID-19 vaccination/vaccine on influenza vaccination from willingness to behavior among older adults in rural China55
Human vaccines & immunotherapeutics: news October 202154
Comment on the “Analysis of the implementation effect and evaluation of the vaccine protection effect of the live attenuated varicella vaccine program for school-age children in Bao’an district of She54
HV&I Reviewer Highlight50
A One Health approach to bovine coronavirus vaccine development, using LSDV as a live virus vector50
Impaired long-term anti-HBs responses in choronic hepatitis C patients: Results from a five-year follow-up study with healthy control49
Improving Tdap maternal immunization rate in Saudi Arabia49
A cross-sectional study assessing Pro-VC-Be short-form questionnaire in Canada; measuring psychosocial determinants of vaccination behavior in Canadian healthcare professionals49
Individual and neighborhood factors associated with being unvaccinated against COVID-19 among pregnant persons49
Immune response to and virological profile of SARS-CoV-2 before and after symptom onset in individuals vaccinated with inactivated COVID-19 vaccines48
Visual analysis of the research frontiers, hotspots and development trends of immunization programs for women and children47
How to make effective HPV vaccine recommendations starting at age 946
Harnessing live vectors for cancer vaccines: Advancing therapeutic immunotherapy46
Medical students’ knowledge about human papillomavirus (HPV), HPV vaccine and head and neck cancer45
Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children45
Efficiency enhancement in main path extraction in mRNA vaccine field: A novel approach leveraging intermediate patents, with shielding origin and terminus patent edges44
Challenges to COVID-19 vaccine introduction in the Democratic Republic of the Congo – a commentary43
Determinants of basic childhood vaccination coverage in European and OECD countries43
Beliefs and barriers of COVID-19 vaccination hesitancy among Sudanese healthcare workers in Sudan: A cross sectional study42
Do Pentavalent (DTwP-Hib-HBV) vaccines have sex-differential nonspecific effects? An observational study41
Human vaccines and immunotherapeutics: News December 202340
Uptake, adverse effect, and associated factors of COVID-19 vaccine among those living with human immunodeficiency virus, at Bole sub-city health facility Addis Ababa, Ethiopia39
COVID-19 vaccine acceptance and hesitancy among ethnic minorities in Hong Kong38
Response to a letter to the editor regarding ‘ the comparison of seroconversion rates among different varicella vaccines administered Turkish children; MAV/06 and vOka’37
Vaccine manufacturing is essential to ensure access37
Enhancing COVID-19 booster vaccination among the elderly through text message reminders36
Implementing interventions to start HPV vaccination at age 9: Using the evidence we have36
Determinants of healthcare workers perceptions, acceptance and choice of COVID-19 vaccines: a cross-sectional study from the United Arab Emirates36
Assessment of caregiver willingness to vaccinate their children against COVID-19 in Saudi Arabia: a cross-sectional study36
Age- and time-dependent waning vaccine effectiveness of PPV23 against community-acquired pneumonia among adults aged 60 and older: A cohort study36
Pertactin deficiency of Bordetella pertussis : Insights into epidemiology, and perspectives on surveillance and public health impact35
Immunogenicity and safety of different schedules of the meningococcal ABCWY vaccine, with assessment of long-term antibody persistence and booster responses – results from two phase 2b randomized tria34
Health, beliefs, and faith: HPV vaccine uptake intent among Catholic, Evangelical, and mainline protestant parents34
Acute encephalitis after COVID-19 vaccination: A case report and literature review33
Single-cell analysis unravels the role of NK cells and monocytes in the control of SARS-CoV-2 breakthrough infections in vaccinated individuals32
Understanding barriers to influenza vaccination among parents is important to improve vaccine uptake among children32
Recent advances in immunotherapy targeting CETP proteins for atherosclerosis prevention32
Immunological non-inferiority and safety of a quadrivalent inactivated influenza vaccine versus two trivalent inactivated influenza vaccines in China: Results from two studies32
Global research trends in CAR-T cell therapy for solid tumors: A comprehensive visualization and bibliometric study (2012–2023)31
Childhood vaccination uptake among children born in Aotearoa New Zealand based on parental nationality31
Long-term follow up of patients treated with a DNA vaccine (pTVG-hp) for PSA-recurrent prostate cancer31
A Bayesian re-analysis of the DANFLU-1 trial31
COVID-19 vaccine uptake and hesitancy among HIV-infected men who have sex with men in mainland China: a cross-sectional survey31
The prevalence and determinants of COVID-19 vaccine hesitancy in the age of infodemic31
The potential effect of HBV vaccination on off-treatment HBsAg reversion after interferon-induced HBsAg clearance31
Human vaccines and immunotherapeutics: News July 202530
Pandemic paradox: How the COVID-19 crisis transformed vaccine hesitancy into a two-edged sword30
Disparities in full immunization coverage among urban and rural children aged 12-23 months in southwest Ethiopia: A comparative cross-sectional study30
Cost-effectiveness of the adjuvanted RSVPreF3 vaccine among adults aged ≥60 years in the United States30
Laboratory-based surveillance in Latin America: attributes and limitations in evaluation of pneumococcal vaccine impact29
Vaccine hesitancy in the refugee, immigrant, and migrant population in the United States: A systematic review and meta-analysis29
Educational intervention for women in Japan coming of age for cervical cancer screening who grew up during the suspended HPV-vaccination-program29
Association between combination COVID-19-influenza vaccination and long COVID in middle-aged and older Europeans: A cross-sectional study29
Herpes zoster vaccination and vaccine preferences among persons aged 50–64 years in Australia: Findings from a discrete choice experiment29
Adverse events following immunization surveillance on two types of enterovirus 71 vaccines: A real-world comparative study in China28
The landscape of COVID-19 vaccination among healthcare workers at the first round of COVID-19 vaccination in China: willingness, acceptance and self-reported adverse effects28
Safety and immunogenicity of full-dose quadrivalent influenza vaccine in children 6–35 months of age in China: A randomized, double-blind, clinical trial28
Exploring the COVID-19 vaccine candidates against SARS-CoV-2 and its variants: where do we stand and where do we go?28
Misconceptions and knowledge gaps about HPV, cervical cancer, and HPV vaccination among Central American immigrant parents in the United States27
Development of a herpes zoster vaccination intention scale and identification of factors associated with vaccine hesitancy among middle-aged and older attendees in community health centers: A Protecti27
Bibliometric and visual analysis of vaccination hesitancy research from 2013 to 202227
Analysis on the epidemiological characteristics of varicella and breakthrough case from 2014 to 2022 in Qingyang City27
Influenza vaccination landscape in Italy: A comprehensive study through the OBVIOUS project lens27
COVID-19 vaccine acceptance in three rural communes in Haiti: A cross-sectional study27
Exploring mother-daughter communication and social media influence on HPV vaccine refusal for daughters aged 9-17 years in a cross-sectional survey of 11,728 mothers in China27
Statistical and machine learning methods for immunoprofiling based on single-cell data27
Mini-review on the therapeutic vaccines targeting chronic infectious diseases: Evaluation system of therapeutic vaccines targeting HPV and EBV-related cancers26
Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Türkiye: A randomized trial26
Risk and safety profile in checkpoint inhibitors on non-small-cell lung cancer: A systematic review26
COVID-19 vaccine hesitancy between teachers and students in a college, a cross-sectional study in China26
Equivalence of freeze-dried and liquid-frozen formulations of MVA-BN as smallpox and mpox vaccine26
Understanding the impact process of vaccine adoption for COVID-1926
Trends in hospitalization and death rates among patients with head and neck cancer in Spain, 2009 to 201926
A new quadrivalent meningococcal tetanus toxoid conjugate vaccine: Menquadfi® (MENACWY-TT)26
Hospitalization burden associated with anus and penis neoplasm in Spain (2016-2020)25
Switching from trivalent to quadrivalent inactivated influenza vaccines in Uruguay: a cost-effectiveness analysis25
Explaining COVID-19 postvaccination-related immune thrombotic thrombocytopenia: a hypothesis-generating in-silico approach25
Validation of self-reported human papillomavirus vaccination in young adult men who have sex with men25
Enhancing vaccine effectiveness in the elderly to counter antibiotic resistance: The potential of adjuvants via pattern recognition receptors25
Reply letter to “Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or old25
Antibody response to sequential vaccination with cell culture, recombinant, or egg-based influenza vaccines among U.S. adults25
Integrating the CARD (Comfort Ask Relax Distract) system in a mass vaccination clinic to improve the experience of individuals during COVID-19 vaccination: a pre-post implementation study24
Post COVID-19 vaccination Guillain-Barre syndrome: three cases24
Adverse events after COVID-19 vaccination self-reported by healthcare workers are reliable24
Autologous engineered T cell receptor therapy in advanced cancer24
Disparate kinetics in immune response of two different Haemophilus influenzae type b conjugate vaccines: Immunogenicity and safety observations from a randomized control24
Mumps serological surveillance following 10 years of a one-dose mumps-containing-vaccine policy in Fujian Province, China23
Revamping the BCG revaccination strategy: Records to recall, or just call it phoenix?23
Using big data to analyze the vaccination status of children with congenital heart disease in Yinzhou District, China23
“Direct and indirect impacts of the COVID-19 pandemic on operational conduct of pediatric vaccine clinical trials”23
Safety of COVID-19 Pfizer-BioNtech (BNT162b2) mRNA vaccination in adolescents aged 12–17 years: A systematic review and meta-analysis23
Omalizumab added to allergen immunotherapy increased the effect of therapy in patients with severe local allergic rhinitis23
An analysis of reported cases shoulder injury related to vaccine administration of after COVID-19 vaccination23
Effectiveness, immunogenicity, and safety of the quadrivalent HPV vaccine in women and men aged 27–45 years23
The long-term impact of vaccine clinical research on national stakeholders involved: Experience from a low-income Country23
Another measles outbreak in the Philippines? The essentiality of a successful vaccination program and public cooperation23
Determinants of immunization defaulters among children aged 12–23 months in Ambo town, Oromia, Ethiopia: A case–control study23
CEA vaccines23
The contributions of T cell-mediated immunity to protection from vaccine-preventable diseases: A primer23
Covid-19 vaccines elicit effective IgG responses in an elderly thymus cancer patient with chemotherapy23
Attitudes and behavior of medical students toward receiving the COVID-19 vaccine23
A review of technological developments in lipid nanoparticle application for mRNA vaccination23
Epidemiological characteristic of rubella by age group during 12 years after the national introduction of rubella vaccine in Hangzhou, China22
Cross-reactive humoral immunity of clade 2 Oka and MAV/06 strain-based varicella vaccines against different clades of varicella–zoster virus22
RSV disease in infants and young children: Can we see a brighter future?22
Public health impact of herpes zoster vaccination on older adults in Hong Kong22
Intention to receive a COVID-19 vaccine booster dose and associated factors in Malaysia22
Multilevel perspectives on school-based opportunities to improve HPV vaccination among medically underserved adolescents: Beyond school entry mandates22
State of pneumococcal vaccine immunity22
HV&I Reviewer Highlight22
“They were saying that it’s the end of the world”: Experiences of COVID-19 and beliefs about the COVID-19 vaccine among refugees in Rhode Island, US22
Survey of pediatricians concerning the human papillomavirus vaccine in Japan: Positive attitudes toward vaccination during the period of proactive recommendation being withheld21
Immunogenicity persistence after four intramuscular triple-dose or standard-dose hepatitis B vaccine in patients receiving methadone maintenance treatment: A 1-year follow-up study in China21
Validation of an interferon-gamma enzyme-linked immunosorbent spot assay to evaluate cell-mediated immunity against severe acute respiratory syndrome coronavirus 221
Review of the unmet medical need for vaccination in adults with immunocompromising conditions: An Indian perspective21
Factors influencing attitudes toward vaccine safety and vaccine effectiveness amongst UK healthcare professionals prior to and at the time of COVID-19 vaccine rollout: Insights from the CoPE-HCP cohor21
Closer adult child–parent relations the stronger the vaccine hesitancy: A cross-sectional study of adult Children’s attitudes toward pneumococcal vaccination of elderly parents and its determinants in21
Healthcare students’ vaccination status, knowledge, and protective behaviors regarding hepatitis B: a cross-sectional study in Turkey21
A study on the willingness and influencing factors of non-EPI vaccines recommendations among Chinese vaccination staff under major infectious disease outbreaks21
Pneumonia hospitalizations of children aged <2 years in Poland before (2013–2016) and after (2017–2018) universal mass vaccination with 10-valent pneumococcal non-typeable Haemophilu21
Diverse processes in rotavirus vaccine development21
Role of gastroenterologists and healthcare providers in promoting COVID-19 immunization among individuals with inflammatory bowel disease: A systematic review and meta-analysis on a global scale21
Development of mRNA rabies vaccines21
Correlates of uptake of COVID-19 vaccines and motivation to vaccinate among Malawian adults21
Comprehensive immunoprofiling and systematic adjuvant comparisons for identifying suitable vaccine: Adjuvant pairings21
Advancements in the development of nucleic acid vaccines for syphilis prevention and control21
COVID-19 vaccine acceptance rate and its predictors in Ethiopia: A systematic review and meta-analysis20
Comment on “Bidirectional crosstalk between the epithelial-mesenchymal transition and immunotherapy: A bibliometric study”20
A retrospective audit of neonatal BCG vaccination in Grampian, Scotland20
A community-wide epidemic of hepatitis A virus genotype IA associated with consumption of shellfish in Yantai, eastern China, January to March 202020
Modifying non-coding regions of linear DNA vaccines to explore the interplay of expression and inflammation in immunogenicity20
Status of COVID-19 vaccination around South Asia20
COVID-19 vaccine booster dose hesitancy among key groups: A cross-sectional study20
A serological investigation in Southern Italy: was SARS-CoV-2 circulating in late 2019?20
Parental intention on getting children COVID-19 vaccinations: Invariance evaluation across parenting roles and COVID-19-like symptoms experiences among Iranians during the pandemic period20
Using the power of innate immunoprofiling to understand vaccine design, infection, and immunity20
Cost-effectiveness of a behavioral insights-informed digital campaign to increase HPV vaccination in Bangladesh20
Vaccination coverage determinants in low uptake areas of China: a qualitative study of provider perspectives in Sichuan, Guangdong, and Henan Provinces20
Response to Letter to the Editor by Amnuay Kleebayoon, Viroj Wiwanitkit titled: Hesitancy toward vaccination against COVID-1920
2024 List of Reviewers20
Comparative analysis of immunogenicity between first-dose measles-mumps-rubella (MMR) vaccine administration and combined MMR-rotavirus vaccination20
The impact of COVID-19 and catch-up strategies on routine childhood vaccine coverage trends in Latin America: A systematic literature review and database analysis19
Mpox vaccination hesitancy and its associated factors among the general population in China: A national observational study19
Effect of difference between EV-A71 virus epidemic strain and “vaccine strain” on neutralizing antibody titer19
Case report: Leptomeningeal metastasis of advanced nasopharyngeal carcinoma treated with chemoimmunotherapy19
Is vaccine hesitancy related to mental health after the adjustment of the zero-COVID-19 strategy in the elderly? A mediation analysis in China19
Efficacy, immunogenicity, and safety of heterologous boosting with a novel chimera Chinese mRNA (RQ3013) SARS-CoV-2 vaccine: A randomized, double-blind, active-controlled trial19
The attitude and knowledge of pediatricians and family physicians toward COVID-19 vaccination in children: A cross-sectional study19
A systematic review of gastritis as an immune-related adverse event in clinical interventions19
Attitude for vaccination prophylaxis among pregnant women: a cross-sectional study19
Exploring nurses’ experiences with a school-located influenza vaccination program: A qualitative study in the region of Murcia, Spain19
Long-term survival after immunotherapy and targeted therapy without chemotherapy in an elderly patient with HER2-positive gastroesophageal junction cancer: A case report19
Seroepidemiological survey of the population 10 years after the implementation of the varicella vaccine 2-dose immunization strategy19
Respiratory syncytial virus immunization with nirsevimab: Acceptance and satisfaction assessment in infants and risk groups in the region of Murcia (Spain)18
Comparing factors influencing seasonal influenza vaccine acceptance and intentions among Chinese university students residing in China and UK: A cross-sectional study18
HV&I reviewer highlight18
Association of provider HPV vaccination training with provider assessment of HPV vaccination status and recommendation of HPV vaccination18
Vaccine hesitancy and its determinants among refugee parents resettled in Aotearoa New Zealand18
Baseline immunity predicts prognosis of pancreatic cancer patients treated with WT1 and/or MUC1 peptide-loaded dendritic cell vaccination and a standard chemotherapy18
Overcoming barriers to HPV vaccination in rural Vermont through a multicomponent peer-based approach18
Comment on: “Efficacy and safety of tebentafusp in patients with metastatic uveal melanoma: A systematic review and meta-analysis”18
Safety and immunogenicity of a modified mRNA-lipid nanoparticle vaccine candidate against COVID-19: Results from a phase 1, dose-escalation study18
Human papillomavirus (HPV) vaccine clinical trials: A cross-sectional analysis of clinical trials registries18
11th Immunotherapy of Cancer conference (ITOC): A meeting report18
Development of a novel multi-epitope mRNA vaccine candidate to combat HMPV virus18
Results of a phase I/IIa trial of SV-BR-1-GM inoculation with low-dose cyclophosphamide and interferon alpha (Bria-IMT) in metastatic breast cancer18
Disparities in healthcare access and utilization and human papillomavirus (HPV) vaccine initiation in the United States18
The influence of social network on COVID-19 vaccine hesitancy among healthcare workers: a cross-sectional survey in Chongqing, China18
Immunogenicity, safety, and tolerability of a β-glucan-CpG-adjuvanted respiratory syncytial virus vaccine in Japanese healthy participants aged 60 to 80 years: A phase 2, randomized, double-blind, dos18
Seasonal influenza vaccination uptake among health and medical college students: A discrete choice experiment18
Analysis on willingness and its influencing factors of influenza vaccination among HCWs in Quzhou in 2022–2023 influenza season18
Lessons learned from 2 years of influenza vaccinations in the UK and USA during the COVID-19 pandemic as respiratory viruses return17
Facilitators to vaccination among hesitant adopters17
Meningococcal serogroup B vaccination series initiation in the United States: A real-world claims data analysis17
Real-world single-center data analysis of dual immunotherapy in advanced NSCLC: Efficacy, survival, and adverse events17
The research status and prospects of MUC1 in immunology17
Immunogenicity and tolerability of a bivalent virus-like particle norovirus vaccine candidate in children from 6 months up to 4 years of age: A phase 2 randomized, double-blind trial17
Hyponatremia predicts immunotherapy resistance in biliary tract cancer17
Systemic sclerosis and vaccinations: a three-year register-based cohort study about vaccination rate and uptake from Liguria referral center, northwest Italy17
Anti-inflammatory effects of immunotherapy in clinical treatment and its potential mechanism in alleviating sleeping disorders: A systematic bibliometric study17
A novel anti-CD47 antibody with therapeutic potential for NK/T-cell lymphoma17
Research progress on chimeric antigen receptor-based immunotherapy against autoimmune diseases17
Building a better antibody through the Fc: advances and challenges in harnessing antibody Fc effector functions for antiviral protection17
Natural carrier systems in cancer vaccines and immunotherapy17
Review of bimekizumab in the treatment of psoriasis17
Thromboembolism after Astra Zeneca COVID-19 vaccine: Not always PF4- antibody mediated17
Neoadjuvant immune checkpoint inhibitors in high-risk stage III melanoma17
Impact of COVID-19 vaccination status on hospitalization and disease severity: A descriptive study in Nagasaki Prefecture, Japan16
Parental intention to vaccinate adolescents with HPV vaccine in selected communities in Ibadan, Southwest Nigeria: an application of Integrated Behavioral Model16
Cost-effectiveness and epidemiological impact of gender-neutral HPV vaccination in Spain16
Systematic literature review and meta-analysis on the prevalence of rotavirus genotypes in Europe and the Middle East in the post-licensure period16
Tumor vaccines: Toward multidimensional anti-tumor therapies16
Response to comment on: “Efficacy and safety of tebentafusp in patients with metastatic uveal melanoma: A systematic review and meta-analysis”16
Prospective, multi-center post-marketing surveillance cohort study to monitor the safety of the human papillomavirus-16/18 AS04-adjuvanted vaccine in Chinese girls and women aged 9 to 45 years, 2018–216
Etiology of pediatric lower respiratory tract infections in South Korea16
Humoral response against spike protein enhanced by fifth and sixth COVID-19 mRNA vaccine in the uninfected and infected subjects16
Protein nanocages: A new frontier in mucosal vaccine delivery and immune activation16
The prospect of orally administered monoclonal secretory IgA (SIgA) antibodies to prevent enteric bacterial infections16
Human vaccines & immunotherapeutics: News March 202316
Simulating rabies post-exposure prophylaxis among patients with human immunodeficiency virus infection using a six-dose Essen regimen administrated with human diploid cell vaccine: A single-arm pilot 16
Respiratory syncytial virus immunization in children: The old, the new and what’s just around the corner16
Enhancing routine immunization efforts for older adults and frail individuals: Good practices during the SARS-CoV-2 pandemic in Italy16
Comparative risk of cerebral venous sinus thrombosis (CVST) following COVID-19 vaccination or infection: A national cohort study using linked electronic health records16
Determinants of parental self-reported uptake of influenza vaccination in preschool children during the COVID-19 pandemic16
Establishment of the 1st Chinese national standard for CA6 neutralizing antibody16
Economic burden of respiratory syncytial virus disease in Latin America: A systematic review16
Parental intention to vaccinate children against seasonal influenza in the Eastern Mediterranean region: A cross-sectional study using the health belief model16
Bibliometric analysis on the progress of immunotherapy in renal cell carcinoma from 2003-202216
Malawi vaccination drive: An integrated immunization campaign against typhoid, measles, rubella, and polio; health benefits and potential challenges16
Bibliometric analysis of dendritic cell-based vaccines over the past 15 years16
Correction16
Safety and Immunogenicity of a novel three-dose recombinant nanoparticle rabies G protein vaccine administered as simulated post exposure immunization: A randomized, comparator controlled, multicenter15
Mothers’ perceptions and attitudes about HPV vaccination initiation among 9- and 10-year-olds15
Evolution of strain coverage by the multicomponent meningococcal serogroup B vaccine (4CMenB) in France15
Why do parents willingness-to-pay to vaccinate their children against COVID-19? A real-world evidence in Taizhou, China15
Missed opportunities for human papillomavirus vaccine series initiation in a large, rural U.S. state15
COVID-19 vaccination up-take in three districts of Nepal15
Prevalence of Neisseria meningitidis serogroups in invasive meningococcal disease in China, 2010 - 2020: a systematic review and meta-analysis15
Immunogenicity and safety of the non-typable Haemophilus influenzaeMoraxella catarrhalis (NTHi-Mcat) vaccine administered following the15
Opportunities for HPV vaccine education in school-based immunization programs in British Columbia, Canada: A qualitative study15
Association between depression and three key COVID-19-related outcomes: The SHARE study15
Safety and reactogenicity of the BNT162b2 COVID-19 vaccine: Development, post-marketing surveillance, and real-world data15
Driving consistency: CEPI-Centralized Laboratory Network’s conversion factor initiative for SARS-CoV-2 clinical assays used for efficacy assessment of COVID vaccines15
Human vaccines & immunotherapeutics: News December 202215
The progress of peptide vaccine clinical trials in gynecologic oncology15
Parents’ willingness to vaccinate their daughters with human papillomavirus vaccine and associated factors in Debretabor town, Northwest Ethiopia: A community-based cross-sectional study15
Navigating vaccine hesitancy: Strategies and dynamics in healthcare professional-parent communication15
Current updates on generations, approvals, and clinical trials of CAR T-cell therapy15
The approach of World Health Organization to articulate the role and assure impact of vaccines against antimicrobial resistance15
0.040245056152344